Breaking News
Get 40% Off 0
🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought it Read More
Close

Roche Holding AG (0QQ6)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
265.80 -38.00    -12.51%
11:31:11 - Closed. Currency in CHF ( Disclaimer )
Type:  Equity
Market:  United Kingdom
ISIN:  CH0012032113 
SEDOL:  BKJ8Y02
  • Volume: 3,008
  • Bid/Ask: 247.80 / 0.00
  • Day's Range: 264.17 - 266.20
Roche Holding 265.80 -38.00 -12.51%

0QQ6 Candlestick Patterns

 
Dozens of bullish and bearish live candlestick chart patterns for the Roche Holding AG stock and use them to predict future market behavior. The Roche Holding stock patterns are available in a variety of time frames for both long and short term investments. Gain a trading edge with the auto pattern recognition feature and gain an insight into what the patterns mean.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Customize

Candlestick Patterns

Time Frame
Pattern Indication
Type
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Three Outside Up 1M Current
Harami Bearish 1W Current
Harami Bullish 1D Current
Completed Patterns
Bullish Engulfing 1M 1 May 24
Three Inside Up 1W 1 Jun 02, 2024
Harami Bullish 1W 2 May 26, 2024
Harami Cross 1W 2 May 26, 2024
Dark Cloud Cover 1W 3 May 19, 2024
Belt Hold Bearish 15 3 Jun 11, 2024 10:45AM
Dark Cloud Cover 15 3 Jun 11, 2024 10:45AM
Shooting Star 1D 4 Jun 05, 2024
Evening Star 5H 5 Jun 10, 2024 12:00AM
Shooting Star 5H 6 Jun 07, 2024 07:00AM
Bullish Hammer 1H 6 Jun 11, 2024 05:00AM
Downside Gap Three Methods 1M 8 Apr 23
Bullish Hammer 1H 8 Jun 11, 2024 03:00AM
Engulfing Bearish 30 9 Jun 11, 2024 07:00AM
Bullish Engulfing 1W 11 Mar 24, 2024
Three Outside Down 1M 12 Dec 22
Falling Three Methods 1M 12 Dec 22
Three Outside Down 1W 12 Mar 17, 2024
Bullish Hammer 15 12 Jun 11, 2024 08:30AM
Engulfing Bearish 1M 13 Nov 22
Engulfing Bearish 1W 13 Mar 10, 2024
Doji Star Bearish 5H 16 Jun 03, 2024 11:00PM
Bullish Engulfing 1M 17 Jul 22
Belt Hold Bearish 1D 17 May 16, 2024
Three Black Crows 1M 18 Jun 22
Bullish Hammer 1M 18 Jun 22
Falling Three Methods 1M 19 May 22
Engulfing Bearish 1D 19 May 14, 2024
Belt Hold Bearish 1D 19 May 14, 2024
Shooting Star 5H 19 May 31, 2024 10:00AM
Shooting Star 15 19 Jun 11, 2024 06:30AM
Harami Bullish 1W 20 Jan 21, 2024
Harami Cross 1W 20 Jan 21, 2024
Engulfing Bearish 1H 20 Jun 07, 2024 08:00AM
Abandoned Baby Bullish 1M 21 Mar 22
Three Inside Up 1M 21 Mar 22
Morning Star 5H 21 May 30, 2024 09:00AM
Dragonfly Doji 1M 22 Feb 22
Harami Bullish 1M 22 Feb 22
Harami Cross 1M 22 Feb 22
Inverted Hammer 5H 22 May 30, 2024 04:00AM
Three Black Crows 1W 24 Jun 04, 2023
Bullish Hammer 15 24 Jun 11, 2024 05:15AM
Harami Bullish 1D 25 May 03, 2024
Doji Star Bearish 1H 26 Jun 06, 2024 11:00AM
Three Outside Up 1H 26 Jun 06, 2024 11:00AM
Engulfing Bearish 1M 27 Sep 21
Upside Gap Three Methods 1M 27 Sep 21
Belt Hold Bullish 1H 27 Jun 06, 2024 10:00AM
Bullish Engulfing 1H 27 Jun 06, 2024 10:00AM
Doji Star Bearish 30 27 Jun 10, 2024 07:00AM
Doji Star Bearish 1W 30 Apr 23, 2023
Bullish doji Star 30 31 Jun 10, 2024 05:00AM
Three Outside Down 5H 32 May 24, 2024 03:00AM
Belt Hold Bearish 5H 33 May 23, 2024 07:00AM
Engulfing Bearish 5H 33 May 23, 2024 07:00AM
Dragonfly Doji 15 33 Jun 11, 2024 03:00AM
Engulfing Bearish 1M 34 Feb 21
Evening Doji Star 1M 34 Feb 21
Dragonfly Doji 1W 34 Mar 26, 2023
Harami Bullish 30 34 Jun 07, 2024 11:30AM
Harami Cross 30 34 Jun 07, 2024 11:30AM
Bullish doji Star 5H 35 May 22, 2024 11:00AM
Three Inside Up 1M 36 Dec 20
Tri-Star Bearish 1H 36 Jun 05, 2024 08:00AM
Harami Bearish 30 36 Jun 07, 2024 10:30AM
Harami Bullish 1M 37 Nov 20
Inverted Hammer 1M 37 Nov 20
Bullish doji Star 15 37 Jun 10, 2024 10:45AM
Harami Bullish 15 37 Jun 10, 2024 10:45AM
Harami Cross 15 37 Jun 10, 2024 10:45AM
Inverted Hammer 1M 39 Sep 20
Harami Bullish 1M 40 Aug 20
Tri-Star Bearish 30 40 Jun 07, 2024 08:30AM
Tri-Star Bearish 1H 43 Jun 04, 2024 09:00AM
Bullish Engulfing 1M 44 Apr 20
Harami Cross 1M 45 Mar 20
Three Black Crows 1D 45 Apr 04, 2024
Engulfing Bearish 1M 46 Feb 20
Deliberation Bearish 1H 47 Jun 04, 2024 03:00AM
Doji Star Bearish 1H 47 Jun 04, 2024 03:00AM
Belt Hold Bearish 30 49 Jun 07, 2024 03:00AM
Three Inside Up 1M 51 Sep 19
Harami Bullish 1D 51 Mar 25, 2024
Belt Hold Bearish 5H 51 May 14, 2024 03:00AM
Engulfing Bearish 5H 51 May 14, 2024 03:00AM
Doji Star Bearish 15 51 Jun 10, 2024 07:00AM
Harami Bullish 1M 52 Aug 19
Harami Cross 1M 52 Aug 19
Homing Pigeon 1D 52 Mar 22, 2024
Three Black Crows 1W 53 Nov 13, 2022
Bullish Engulfing 1M 54 Jun 19
Tri-Star Bullish 15 54 Jun 10, 2024 06:00AM
Three Black Crows 1M 55 May 19
Bullish Hammer 1D 55 Mar 19, 2024
Dark Cloud Cover 1H 55 May 31, 2024 11:00AM
Belt Hold Bullish 30 55 Jun 06, 2024 08:30AM
Bullish doji Star 15 57 Jun 10, 2024 04:45AM
Deliberation Bearish 30 59 Jun 06, 2024 04:30AM
Doji Star Bearish 30 59 Jun 06, 2024 04:30AM
Engulfing Bearish 1M 60 Dec 18
Belt Hold Bearish 1M 60 Dec 18
Tri-Star Bullish 15 60 Jun 07, 2024 11:30AM
Hanging Man 1M 62 Oct 18
Hanging Man 30 62 Jun 06, 2024 03:00AM
Evening Star 1M 63 Sep 18
Bullish doji Star 30 63 Jun 05, 2024 11:30AM
Deliberation Bearish 1M 64 Aug 18
Harami Cross Bearish 15 65 Jun 07, 2024 10:15AM
Tri-Star Bearish 30 66 Jun 05, 2024 08:00AM
Belt Hold Bearish 15 67 Jun 07, 2024 09:45AM
Belt Hold Bullish 1H 68 May 30, 2024 04:00AM
Tri-Star Bearish 30 68 Jun 05, 2024 05:00AM
Belt Hold Bullish 5H 69 Apr 30, 2024 09:00AM
Bullish Engulfing 5H 69 Apr 30, 2024 09:00AM
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

RO Comments

Write your thoughts about Roche Holding AG
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Joe Jordan
Joe Jordan May 21, 2024 5:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
FDA Grants Breakthrough Therapy Designation to Genentech’s Inavolisib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer with a PIK3CA Mutation
Joe Jordan
Joe Jordan May 21, 2024 5:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Roche To Ride Booming Obesity Treatment Market With Newly-Acquired Drug Candidate Thursday, Genentech, a unit of Roche Holdings AG (OTC:RHHBY), released results from the Phase 1b trial of CT-388, a dual GLP-1/GIP receptor agonist being developed for the treatment of obesity and type 2 diabetes. The study found that a once-weekly subcutaneous injection of CT-388 over 24 weeks resulted in significant weight loss in healthy adults with obesity compared to placebo.
Sherlyn Jones
Sherlyn Jones Apr 22, 2021 6:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
A large pharmaceutical company, by the name of R. , is pushing down the value of the Spanish company's Pharmamar share price through the funds Consonance Capital and Great Point Partners, so that the biotech company accepts its offer of more than 4500 million dollars.According to this pharma, Pharmamar's products have a great future in oncology and virology, and would be fully engaged in its search for new drugs.
Lee John
Lee John Nov 16, 2020 3:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
13.11.2020. CHMP recommends EU approval of Roche’s Xofluza® (baloxavir marboxil) for the treatment of influenza. This CHMP recommendation brings patients with influenza one step closer to potentially benefiting from Xofluza’s oral one-dose regimen, setting adults and adolescents on the path to feeling better sooner compared to placebo,” said Levi Garraway, M.D., Ph.D., Roche’s Chief Medical Officer and Head of Global Product Development. “We believe that access to effective antivirals for influenza, and particularly their use in the prophylactic setting, could help reduce the strain of the COVID-19 pandemic on healthcare systems in Europe.
Jonny Tr
Jonny Tr May 04, 2020 8:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Just like Biolidics. they get approval for Covid19 tests kits in USA
Billy Hanafi
Billy Hanafi Jan 25, 2019 10:12AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i dont know
edgard hajjar
edgard hajjar May 07, 2018 5:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
is the historical price adjusted for stock splits?
Billy Hanafi
Billy Hanafi May 07, 2018 5:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i dont know
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email